Literature DB >> 22038288

Invertebrate models of lysosomal storage disease: what have we learned so far?

Samantha Hindle1, Sarita Hebbar, Sean T Sweeney.   

Abstract

The lysosomal storage diseases (LSDs) collectively account for death in 1 in 8,000 children. Although some forms are treatable, they are essentially incurable and usually are lethal in the first decade of life. The most intractable forms of LSD are those with neuronal involvement. In an effort to identify the pathological signaling driving pathology in the LSDs, invertebrate models have been developed. In this review, we outline our current understanding of LSDs and recent findings using invertebrate models. We outline strategies and pitfalls for the development of such models. Available models of LSD in Drosophila and Caenorhabditis elegans are uncovering roles for LSD-related proteins with previously unknown function using both gain-of-function and loss-of-function strategies. These models of LSD in Drosophila and C. elegans have identified potential pathogenic signaling cascades that are proving critical to our understanding of these lethal diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038288     DOI: 10.1007/s10158-011-0125-2

Source DB:  PubMed          Journal:  Invert Neurosci        ISSN: 1354-2516


  93 in total

Review 1.  Tay-Sachs disease.

Authors:  Jose Americo Fernandes Filho; Barbara E Shapiro
Journal:  Arch Neurol       Date:  2004-09

2.  Targeting of NPC1 to late endosomes involves multiple signals, including one residing within the putative sterol-sensing domain.

Authors:  Catherine Scott; Maureen E Higgins; Joanna P Davies; Yiannis A Ioannou
Journal:  J Biol Chem       Date:  2004-09-03       Impact factor: 5.157

Review 3.  Lipid imbalance in the neurological disorder, Niemann-Pick C disease.

Authors:  Jean E Vance
Journal:  FEBS Lett       Date:  2006-06-15       Impact factor: 4.124

4.  Distribution of ectopic neurite growth and other geometrical distortions of CNS neurons in feline GM2 gangliosidosis.

Authors:  S U Walkley; S Wurzelmann; M C Rattazzi; H J Baker
Journal:  Brain Res       Date:  1990-02-26       Impact factor: 3.252

5.  The cation channel mucolipin-1 is a bifunctional protein that facilitates membrane remodeling via its serine lipase domain.

Authors:  Janice M LaPlante; John L Falardeau; Edward M Brown; Susan A Slaugenhaupt; Peter M Vassilev
Journal:  Exp Cell Res       Date:  2011-01-20       Impact factor: 3.905

6.  Neuro-ophthalmology of late-onset Tay-Sachs disease (LOTS).

Authors:  J C Rucker; B E Shapiro; Y H Han; A N Kumar; S Garbutt; E L Keller; R J Leigh
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

7.  Oxidative stress in Niemann-Pick disease, type C.

Authors:  Rao Fu; Nicole M Yanjanin; Simona Bianconi; William J Pavan; Forbes D Porter
Journal:  Mol Genet Metab       Date:  2010-07-27       Impact factor: 4.797

Review 8.  Glycosphingolipid degradation and animal models of GM2-gangliosidoses.

Authors:  T Kolter; K Sandhoff
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

9.  Non-neuronopathic Gaucher disease due to saposin C deficiency.

Authors:  A Tylki-Szymańska; B Czartoryska; M-T Vanier; B J M H Poorthuis; J A E Groener; A Ługowska; G Millat; A M Vaccaro; E Jurkiewicz
Journal:  Clin Genet       Date:  2007-10-07       Impact factor: 4.438

10.  The neurogenetics of mucolipidosis type IV.

Authors:  G Altarescu; M Sun; D F Moore; J A Smith; E A Wiggs; B I Solomon; N J Patronas; K P Frei; S Gupta; C R Kaneski; O W Quarrell; S A Slaugenhaupt; E Goldin; R Schiffmann
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

View more
  5 in total

Review 1.  Model organism data evolving in support of translational medicine.

Authors:  Douglas G Howe; Judith A Blake; Yvonne M Bradford; Carol J Bult; Brian R Calvi; Stacia R Engel; James A Kadin; Thomas C Kaufman; Ranjana Kishore; Stanley J F Laulederkind; Suzanna E Lewis; Sierra A T Moxon; Joel E Richardson; Cynthia Smith
Journal:  Lab Anim (NY)       Date:  2018-09-17       Impact factor: 12.625

2.  A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin.

Authors:  Kerri J Kinghorn; Sebastian Grönke; Jorge Iván Castillo-Quan; Nathaniel S Woodling; Li Li; Ernestas Sirka; Matthew Gegg; Kevin Mills; John Hardy; Ivana Bjedov; Linda Partridge
Journal:  J Neurosci       Date:  2016-11-16       Impact factor: 6.167

3.  Lipid metabolic perturbation is an early-onset phenotype in adult spinster mutants: a Drosophila model for lysosomal storage disorders.

Authors:  Sarita Hebbar; Avinash Khandelwal; R Jayashree; Samantha J Hindle; Yin Ning Chiang; Joanne Y Yew; Sean T Sweeney; Dominik Schwudke
Journal:  Mol Biol Cell       Date:  2017-10-18       Impact factor: 4.138

Review 4.  A Great Catch for Investigating Inborn Errors of Metabolism-Insights Obtained from Zebrafish.

Authors:  Maximilian Breuer; Shunmoogum A Patten
Journal:  Biomolecules       Date:  2020-09-22

Review 5.  Exploiting the Potential of Drosophila Models in Lysosomal Storage Disorders: Pathological Mechanisms and Drug Discovery.

Authors:  Laura Rigon; Concetta De Filippis; Barbara Napoli; Rosella Tomanin; Genny Orso
Journal:  Biomedicines       Date:  2021-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.